Osteoporosis International

, Volume 26, Issue 9, pp 2375–2380 | Cite as

The relationship between serum 25(OH)D and bone density and microarchitecture as measured by HR-pQCT

  • S. K. BoydEmail author
  • L. A. Burt
  • L. K. Sevick
  • D. A. Hanley
Short Communication



The relation between serum 25-hydroxy vitamin D [25(OH)D] and bone quality is not well understood, particularly for high levels. We measured bone microarchitecture in three groups of people stratified by their serum 25(OH)D. There was a weak association of serum 25(OH)D and microarchitecture for this cross-sectional population, suggesting possible benefits to bone quality.


Vitamin D plays an important role in bone and mineral metabolism, but the relation between serum 25(OH)D and bone quality is not well understood. Here, we present a cross-sectional study that investigated a convenience group of participants from an ongoing health initiative in Alberta, Canada, who have been receiving daily vitamin D supplementation.


A total of 105 participants were organized into three groups based on their serum 25(OH)D levels: low (<75 nmol/L), medium (75–175 nmol/L), and high (>175 nmol/L). They were also assessed with 25(OH)D as a continuous variable. Average daily supplementation was 7670 ± 438 IU, and the change in 25(OH)D ranged from 22 to 33 % during the period of receiving supplements. We used high-resolution peripheral quantitative computed tomography measurements at the radius and tibia to assess bone microarchitecture.


Microarchitectural parameters were not strongly associated with serum 25(OH)D. In the tibia, there were fewer trabeculae (TbN; p = 0.015) and a non-significant trend toward thicker trabeculae (p = 0.067) of the high group. Body mass index (BMI) was negatively associated with serum 25(OH)D levels (p < 0.001) and PTH levels (p < 0.001). There was no clinically significant relationship detected between high serum 25(OH)D and high serum calcium.


These data suggest a weak relationship between serum 25(OH)D and bone microarchitecture in this population of mostly vitamin-D-sufficient participants, and there were no indications of negative effects related to the high supplementation levels. These data provided a basis to design and implement our 3-year dose-dependent randomized controlled trial investigating the effects of vitamin D supplementation on bone health outcomes.


25(OH)D Bone microarchitecture Calcium HR-pQCT Vitamin D 



This work was funded by Pure North S’Energy Foundation (Calgary, Alberta). Technical support was provided by Ken Fyie, Michelle Kan, and John Schipilow.

Conflicts of interest



  1. 1.
    Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DCGoogle Scholar
  2. 2.
    Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD (2010) Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 182:1315–1319PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Reid IR, Bolland MJ, Grey A (2013) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. LancetGoogle Scholar
  5. 5.
    Rosen CJ (2013) Vitamin D supplementation: bones of contention. LancetGoogle Scholar
  6. 6.
    Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almas B, Jorde R (2012) The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial. Osteoporos Int 23:201–211PubMedCrossRefGoogle Scholar
  7. 7.
    Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85:6–18PubMedGoogle Scholar
  8. 8.
    Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DA, Muskiet FA (2012) Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 108:1557–1561PubMedCrossRefGoogle Scholar
  9. 9.
    Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:6508–6515PubMedCrossRefGoogle Scholar
  10. 10.
    Macdonald HM, Nishiyama KK, Kang J, Hanley DA, Boyd SK (2011) Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study. J Bone Miner Res 26:50–62PubMedCrossRefGoogle Scholar
  11. 11.
    Buie HR, Campbell GM, Klinck RJ, MacNeil JA, Boyd SK (2007) Automatic segmentation based on a dual threshold technique for in vivo micro-CT bone analysis. Bone 41:505–515PubMedCrossRefGoogle Scholar
  12. 12.
    Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK (2010) Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone 47:519–528PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    MacNeil JA, Boyd SK (2007) Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys 29:1096–1105PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2015

Authors and Affiliations

  • S. K. Boyd
    • 1
    • 2
    Email author
  • L. A. Burt
    • 1
  • L. K. Sevick
    • 1
  • D. A. Hanley
    • 1
  1. 1.McCaig Institute for Bone and Joint HealthUniversity of CalgaryCalgaryCanada
  2. 2.Department of RadiologyUniversity of CalgaryCalgaryCanada

Personalised recommendations